Toggle Nav
mobile icon
My Cart
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area mapk raf'

Search results for: 'research area mapk raf'

Items 1-10 of 208

Page
per page
  1. DiscoveryProbe™ MAPK Inhibitor Library
    L1043 DiscoveryProbe™ MAPK Inhibitor Library
    Summary: A unique collection of 117 MAPK inhibitors for MAPK signaling pathway research.
  2. Sorafenib
    A3009 Sorafenib
     2 Citation
    Target: Raf|VEGFR
    Summary: Raf kinases and tyrosine kinases inhibitor
      ≥23.25 mg/mL
  3. Anti-A RAF Rabbit Monoclonal Antibody
    MA1028 Anti-A RAF Rabbit Monoclonal Antibody
    Summary: Anti-A RAF Rabbit Monoclonal Antibody
  4. Vemurafenib (PLX4032, RG7204)
    A3004 Vemurafenib (PLX4032, RG7204)
     9 Citation
    Target: Raf
    Summary: BRAF kinase inhibitor
      ≥24.5 mg/mL
  5. SB202190 (FHPI)
    A1632 SB202190 (FHPI)
     5 Citation
    Target: p38
    Summary: P38 MAPK inhibitor
  6. Sorafenib Tosylate
    A8245 Sorafenib Tosylate
     1 Citation
    Target: Raf|VEGFR
    Summary: Raf kinases and tyrosine kinases inhibitor
      ≥31.85 mg/mL
  7. Dabrafenib Mesylate (GSK-2118436)
    A3347 Dabrafenib Mesylate (GSK-2118436)
    Target: Raf
    Summary: Inhibitor of BRAF(V600) mutants
      ≥30.75 mg/mL
  8. Human cRAF-RBD with N-terminal His Tag
    P2009 Human cRAF-RBD with N-terminal His Tag
    Summary: Recombinant human RAF proto-oncogene serine/threonine protein kinase, cRAF-RBD.
  9. Regorafenib
    A8236 Regorafenib
     4 Citation
    Target: Raf|VEGFR|PDGFR|c-Kit|RET
    Summary: Inhibitor of VEGFR/PDGFR/FGFR/mutant kit/RET/Raf-1
      ≥25.04 mg/mL
  10. RAF265
    A8313 RAF265
    Target: Raf|VEGFR
    Summary: Multiple intracellular kinases inhibitor
      ≥25.9 mg/mL

Items 1-10 of 208

Page
per page